ENTG Entourage Health Corp

Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced today that the Company's first quarter 2023 financial results will be released after market close on Monday, May 29, 2023.  The Company will host a conference call to discuss these results and provide an operational update as well as recap of achievements on Tuesday, May 30, 2023 at 10 a.m. Eastern Time.

CEO and Executive Chairman George Scorsis and CFO Vaani Maharaj will host the call. Management will be available for questions following the opening remarks.

Conference Call Details:

Date:Tuesday, May 30, 2023

Time:10 a.m. Eastern Time

Dial-in Number:Canada/USA: 1-800-319-4610International Toll: 1-604-638-5340

Participants, please dial in and ask to join the Entourage call

Replay Dial-in:Canada/USA: 1-800-319-6413. International Toll: 1-604-638-9010Replay Access Code: 0167

Available after 12:00 p.m. Eastern Time, until June 30, 2023

For more information, please visit us at www.entouragehealthcorp.com

Common Share Issuance

The Company also announced the issuance of 1,423,057 common shares from treasury following its receipt of approval of the TSX Venture Exchange with respect to a previously-announced shares for debt transaction, in satisfaction of $42,691.65 owing to certain employees of the Company for excess and unused accrued vacation as at December 31, 2022. The common shares issued in connection with the transaction are subject to a hold period until September 12, 2023.

About Entourage Health Corp.

Entourage Health Corp. is the publicly traded parent Company of Entourage Brands Corp. and CannTx Life Sciences Inc., licence holders producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a state-of-the-art hybrid greenhouse and processing facility located on 158-acres in Strathroy, ON; a fully licensed 26,000 sq. ft. Aylmer, ON processing facility. With its Starseed Medicinal medical-centric brand, Entourage has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with employers and union groups complements Entourage’s direct sales to medical patients. With the launch of Syndicate, Entourage now hosts another unique medical marketplace that offers patients a collective of Canadian micro-cultivators’ products, along with Entourage’s family of brands. Entourage’s elite adult-use product portfolio includes Color Cannabis and Saturday Cannabis – sold across eight provincial distribution agencies. It is the exclusive Canadian producer and distributor of award-winning U.S.-based wellness brand Mary’s Medicinals sold in both medical and adult-use channels. Under a collaboration with The Boston Beer Company subsidiary, Entourage is also the exclusive distributor of cannabis-infused beverages ‘TeaPot’ in Canada, which launched in summer 2022, starting in select provinces. In addition, Entourage also entered into an exclusive agreement with Irwin Naturals, a renowned nutraceutical and herbal supplement formulator of popular branded wellness products sold across North America. The new line of CBD soft gels is now available on Starseed’s medical platform.

Follow Entourage and its brands on LinkedInTwitter: Entourage, Color Cannabis, Saturday Cannabis, Starseed & SyndicateInstagram: Entourage, Color Cannabis, Saturday Cannabis, Starseed, & Syndicate

For Investor & Media Enquiries:Catherine FlamanSenior Director, Communications & Corporate Affairs416-910-0279Catherine.flaman@entouragecorp.com

Forward Looking Information This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon Entourage's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified using forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.

The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions, and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance, or other statements that are not statements of fact. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of Entourage to implement its business strategies; the COVID-19 pandemic; competition; crop failure; and other risks.

Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, Entourage does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for Entourage to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in Entourage’s disclosure documents filed with the applicable Canadian securities' regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE